Considering all these results, previously a role of ERβ as putative tumor suppressor has been suggested for a variety of cancer entities like prostate cancer, breast cancer, ovarian cancer or malignant pleural mesothelioma [36, 37]. Here, ESR2 is linked to breast cancer.